Literature DB >> 33165829

Loss-of-Function Plays a Major Role in Early Neurogenesis of Tubulin α-1 A (TUBA1A) Mutation-Related Brain Malformations.

Liangqun Xie1, Jingrui Huang1, Lei Dai1, Jiefeng Luo1, Jiejie Zhang1, Qiaozhen Peng1, Jingchi Sun1, Weishe Zhang2,3.   

Abstract

Tubulin α-1 A (TUBA1A) mutations cause a wide spectrum of brain abnormalities. Although many mutations have been identified and functionally verified, there are clearly many more, and the relationship between TUBA1A mutations and brain malformations remains unclear. The aim of this study was to identify a TUBA1A mutation in a fetus with severe brain abnormalities, verify it functionally, and determine the mechanism of the mutation-related pathogenesis. A de novo missense mutation of the TUBA1A gene, c.167C>G p.T56R/P.THR56Arg, was identified by exon sequencing. Computer simulations showed that the mutation results in a disruption of lateral interactions between the microtubules. Transfection of 293T cells with TUBA1A p.T56R showed that the mutated protein is only partially incorporated into the microtubule network, resulting in a decrease in the rate of microtubule re-integration in comparison with the wild-type protein. The mechanism of pathological changes induced by the mutant gene was determined by knockdown and overexpression. It was found that knockdown of TUBA1A reduced the generation of neural progenitor cells, while overexpression of wild-type or mutant TUBA1A promoted neurogenesis. Our identification and functional verification of the novel TUBA1A mutation extends the TUBA1A gene-phenotype database. Loss-of-function of TUBA1A was shown to play an important role in early neurogenesis of TUBA1A mutation-related brain malformations.

Entities:  

Keywords:  Brain malformation; Loss-of-function; Neurogenesis; TUBA1A; Whole-exome sequencing (WES)

Mesh:

Substances:

Year:  2020        PMID: 33165829     DOI: 10.1007/s12035-020-02193-w

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  34 in total

1.  A pachygyria-causing alpha-tubulin mutation results in inefficient cycling with CCT and a deficient interaction with TBCB.

Authors:  Guoling Tian; Xiang-Peng Kong; Xavier H Jaglin; Jamel Chelly; David Keays; Nicholas J Cowan
Journal:  Mol Biol Cell       Date:  2008-01-16       Impact factor: 4.138

Review 2.  TUBA1A mutation-associated lissencephaly: case report and review of the literature.

Authors:  Aman P S Sohal; Tara Montgomery; Dipayan Mitra; Venkateswaran Ramesh
Journal:  Pediatr Neurol       Date:  2012-02       Impact factor: 3.372

3.  TUBA1A Mutation Associated With Eye Abnormalities in Addition to Brain Malformation.

Authors:  Kenneth A Myers; Luis E Bello-Espinosa; Amin Kherani; Xing-Chang Wei; Allan Micheil Innes
Journal:  Pediatr Neurol       Date:  2015-07-22       Impact factor: 3.372

4.  The wide spectrum of tubulinopathies: what are the key features for the diagnosis?

Authors:  Nadia Bahi-Buisson; Karine Poirier; Franck Fourniol; Yoann Saillour; Stéphanie Valence; Nicolas Lebrun; Marie Hully; Catherine Fallet Bianco; Nathalie Boddaert; Caroline Elie; Karine Lascelles; Isabelle Souville; Cherif Beldjord; Jamel Chelly
Journal:  Brain       Date:  2014-06       Impact factor: 13.501

5.  Recognizable cerebellar dysplasia associated with mutations in multiple tubulin genes.

Authors:  Renske Oegema; Thomas D Cushion; Ian G Phelps; Seo-Kyung Chung; Jennifer C Dempsey; Sarah Collins; Jonathan G L Mullins; Tracy Dudding; Harinder Gill; Andrew J Green; William B Dobyns; Gisele E Ishak; Mark I Rees; Dan Doherty
Journal:  Hum Mol Genet       Date:  2015-06-30       Impact factor: 6.150

6.  Large spectrum of lissencephaly and pachygyria phenotypes resulting from de novo missense mutations in tubulin alpha 1A (TUBA1A).

Authors:  Karine Poirier; David A Keays; Fiona Francis; Yoann Saillour; Nadia Bahi; Sylvie Manouvrier; Catherine Fallet-Bianco; Laurent Pasquier; Annick Toutain; Françoise Phan Dinh Tuy; Thierry Bienvenu; Sylvie Joriot; Sylvie Odent; Dorothée Ville; Isabelle Desguerre; Alice Goldenberg; Marie-Laure Moutard; Jean-Pierre Fryns; Hilde van Esch; Robert J Harvey; Christian Siebold; Jonathan Flint; Chérif Beldjord; Jamel Chelly
Journal:  Hum Mutat       Date:  2007-11       Impact factor: 4.878

Review 7.  Tubulin genes and malformations of cortical development.

Authors:  Romina Romaniello; Filippo Arrigoni; Andrew E Fry; Maria T Bassi; Mark I Rees; Renato Borgatti; Daniela T Pilz; Thomas D Cushion
Journal:  Eur J Med Genet       Date:  2018-07-17       Impact factor: 2.708

Review 8.  Role of cytoskeletal abnormalities in the neuropathology and pathophysiology of type I lissencephaly.

Authors:  Gaëlle Friocourt; Pascale Marcorelles; Pascale Saugier-Veber; Marie-Lise Quille; Stephane Marret; Annie Laquerrière
Journal:  Acta Neuropathol       Date:  2010-11-03       Impact factor: 17.088

9.  Mutations in alpha-tubulin cause abnormal neuronal migration in mice and lissencephaly in humans.

Authors:  David A Keays; Guoling Tian; Karine Poirier; Guo-Jen Huang; Christian Siebold; James Cleak; Peter L Oliver; Martin Fray; Robert J Harvey; Zoltán Molnár; Maria C Piñon; Neil Dear; William Valdar; Steve D M Brown; Kay E Davies; J Nicholas P Rawlins; Nicholas J Cowan; Patrick Nolan; Jamel Chelly; Jonathan Flint
Journal:  Cell       Date:  2007-01-12       Impact factor: 41.582

Review 10.  The mutational and phenotypic spectrum of TUBA1A-associated tubulinopathy.

Authors:  Moritz Hebebrand; Ulrike Hüffmeier; Regina Trollmann; Ute Hehr; Steffen Uebe; Arif B Ekici; Cornelia Kraus; Mandy Krumbiegel; André Reis; Christian T Thiel; Bernt Popp
Journal:  Orphanet J Rare Dis       Date:  2019-02-11       Impact factor: 4.123

View more
  1 in total

1.  Deciphering transcriptome alterations in bone marrow hematopoiesis at single-cell resolution in immune thrombocytopenia.

Authors:  Yan Liu; Xinyi Zuo; Peng Chen; Xiang Hu; Zi Sheng; Anli Liu; Qiang Liu; Shaoqiu Leng; Xiaoyu Zhang; Xin Li; Limei Wang; Qi Feng; Chaoyang Li; Ming Hou; Chong Chu; Shihui Ma; Shuwen Wang; Jun Peng
Journal:  Signal Transduct Target Ther       Date:  2022-10-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.